1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23773
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKoniari, I.en
dc.contributor.authorSiminelakis, S. N.en
dc.contributor.authorBaikoussis, N. G.en
dc.contributor.authorPapadopoulos, G.en
dc.contributor.authorGoudevenos, J.en
dc.contributor.authorApostolakis, E.en
dc.date.accessioned2015-11-24T19:35:56Z-
dc.date.available2015-11-24T19:35:56Z-
dc.identifier.issn1749-8090-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23773-
dc.rightsDefault Licence-
dc.subjectAcute Coronary Syndrome/therapyen
dc.subjectAngioplasty, Balloon, Coronaryen
dc.subjectAntibodies, Antiphospholipid/physiologyen
dc.subject*Antiphospholipid Syndrome/complications/diagnosis/physiopathologyen
dc.subjectCardiac Surgical Proceduresen
dc.subjectCardiovascular Diseases/*diagnosis/physiopathologyen
dc.subjectCoronary Restenosisen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectIntraoperative Complicationsen
dc.subjectPregnancyen
dc.subjectPregnancy Complications/physiopathologyen
dc.subjectThrombosis/etiology/*physiopathology/therapyen
dc.titleAntiphospholipid syndrome; its implication in cardiovascular diseases: a reviewen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1186/1749-8090-5-101-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/21047408-
heal.identifier.secondaryhttp://www.cardiothoracicsurgery.org/content/pdf/1749-8090-5-101.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2010-
heal.abstractAntiphospholipid syndrome (APLS) is a rare syndrome mainly characterized by several hyper-coagulable complications and therefore, implicated in the operated cardiac surgery patient. APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus formation, pulmonary hypertension and dilated cardiomyopathy. The most commonly affected valve is the mitral, followed by the aortic and tricuspid valve. For APLS diagnosis essential is the detection of so-called antiphospholipid antibodies (aPL) as anticardiolipin antibodies (aCL) or lupus anticoagulant (LA). Minor alterations in the anticoagulation, infection, and surgical stress may trigger widespread thrombosis. The incidence of thrombosis is highest during the following perioperative periods: preoperatively during the withdrawal of warfarin, postoperatively during the period of hypercoagulability despite warfarin or heparin therapy, or postoperatively before adequate anticoagulation achievement. Cardiac valvular pathology includes irregular thickening of the valve leaflets due to deposition of immune complexes that may lead to vegetations and valve dysfunction; a significant risk factor for stroke. Patients with APLS are at increased risk for thrombosis and adequate anticoagulation is of vital importance during cardiopulmonary bypass (CPB). A successful outcome requires multidisciplinary management in order to prevent thrombotic or bleeding complications and to manage perioperative anticoagulation. More work and reporting on anticoagulation management and adjuvant therapy in patients with APLS during extracorporeal circulation are necessary.en
heal.journalNameJ Cardiothorac Surgen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Koniari-2010-Antiphospholipid syn.pdf528.97 kBAdobe PDFView/Open
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons